18-366
Showing 1 - 25 of >10,000
COVID-19 (Healthy Volunteers) Trial in United States (SARS-CoV-2 vaccine formulation 1 with adjuvant 1, SARS-CoV-2 vaccine
Completed
- COVID-19 (Healthy Volunteers)
- SARS-CoV-2 vaccine formulation 1 with adjuvant 1
- +5 more
-
Birmingham, Alabama
- +10 more
Apr 22, 2022
Patients Undergoing Percutaneous Biliary Drainage
Active, not recruiting
- Malignant Biliary Obstruction
- FACT-Hep
-
Basking Ridge, New Jersey
- +4 more
Aug 8, 2022
Influenza Immunization Trial in Indianapolis (Quadrivalent Influenza mRNA Vaccine MRT5410, Quadrivalent Recombinant Influenza
Recruiting
- Influenza Immunization
- Quadrivalent Influenza mRNA Vaccine MRT5410
- +3 more
-
San Diego, California
- +19 more
Jan 31, 2023
Influenza Trial in Durham (Influenza Virus Quadrivalent Inactivated Vaccine, Sodium Chloride, 0.9%, VRC-FLUNPF099-00-VP
Not yet recruiting
- Influenza
- Influenza Virus Quadrivalent Inactivated Vaccine
- +2 more
-
Durham, North CarolinaDuke Human Vaccine Institute - Duke Vaccine and Trials Unit
Feb 23, 2023
Influenza Immunization Trial in Puerto Rico, United States (Quadrivalent Influenza mRNA Vaccine MRT5413, Quadrivalent
Recruiting
- Influenza Immunization
- Quadrivalent Influenza mRNA Vaccine MRT5413
- +3 more
-
Long Beach, California
- +23 more
Jan 31, 2023
COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)
Completed
- COVID-19
- COVID-19 Immunisation
- mRNA-1273
-
Decatur, Georgia
- +2 more
Jan 26, 2023
Influenza (Healthy Volunteers) Trial in Melbourne, Peoria (mRNA NA vaccine, High Dose Quadrivalent Influenza Vaccine)
Recruiting
- Influenza (Healthy Volunteers)
- mRNA NA vaccine
- High Dose Quadrivalent Influenza Vaccine
-
Melbourne, Florida
- +1 more
Jun 29, 2022
Influenza Immunization Trial (Quadrivalent Influenza mRNA Vaccine MRT5407, Quadrivalent Recombinant Influenza Vaccine,
Recruiting
- Influenza Immunization
- Quadrivalent Influenza mRNA Vaccine MRT5407
- +3 more
-
Riverside, California
- +28 more
Nov 29, 2022
Anthrax Trial in United States (AV7909 Full Dose (0.5 mL), AV7909 Half Dose (0.25 mL))
Not yet recruiting
- Anthrax
- AV7909 Full Dose (0.5 mL)
- AV7909 Half Dose (0.25 mL)
-
Hickory, North Carolina
- +6 more
Aug 10, 2023
Prevention of COVID-19 Caused by SARS-CoV-2 Trial in Chengdu (randomized, double-blinded, -controlled)
Active, not recruiting
- Prevention of COVID-19 Caused by SARS-CoV-2
- randomized, double-blinded, placebo-controlled
-
Chengdu, ChinaWest China Second University Hospital
Jan 9, 2023
Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)
Recruiting
- Covid19
- CVXGA1 low dose
- CVXGA1 high dose
-
Bardstown, Kentucky
- +3 more
Aug 16, 2022
Extraintestinal Pathogenic Escherichia Coli Prevention Trial in Worldwide (ExPEC10V, ExPEC4V, Prevnar 13)
Active, not recruiting
- Extraintestinal Pathogenic Escherichia Coli Prevention
- ExPEC10V
- +3 more
-
Huntsville, Alabama
- +28 more
Jan 17, 2023
Hypertension Trial in New Orleans (Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension
Not yet recruiting
- Hypertension
- Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension clinical guideline
-
New Orleans, LouisianaTulane University
Nov 10, 2023
Cardiovascular Diseases, Hypertension, Diabetes Trial in New Orleans (Evidence-based interventions recommended by the 2019
Not yet recruiting
- Cardiovascular Diseases
- +3 more
- Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
-
New Orleans, LouisianaTulane University
Sep 26, 2023
Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT, Placebo)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV MAT
- Placebo
-
Birmingham, Alabama
- +162 more
Dec 22, 2022
NSCLC Trial in Worldwide (FKB238 (bevacizumab), Avastin (bevacizumab), Paclitaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- FKB238 (bevacizumab)
- +3 more
-
Fountain Valley, California
- +146 more
Feb 25, 2022
Multiple Chronic Conditions, Decision Making, Shared Trial in West Haven, Houston (Patient Priorities Care, Usual Care)
Recruiting
- Multiple Chronic Conditions
- Decision Making, Shared
- Patient Priorities Care
- Usual Care
-
West Haven, Connecticut
- +1 more
Sep 16, 2022
Meningococcal Immunisation Trial in Puerto Rico, United States (Multicomponent Meningococcal B Vaccine, Meningococcal Group B
Recruiting
- Meningococcal Immunisation
- Multicomponent Meningococcal B Vaccine
- +4 more
-
Guntersville, Alabama
- +21 more
Jan 30, 2023
Lung Tumors, PET-CT Specimen Imager Trial in Ghent (AURA10 Specimen Imager)
Not yet recruiting
- Lung Neoplasms
- PET-CT Specimen Imager
- AURA10 Specimen Imager
-
Ghent, BelgiumUniversity Hospital Ghent
Jan 11, 2023
Healthy Trial in Valencia (High-intensity and short-duration, Low-intensity and long-duration, High-intensity, short-duration
Recruiting
- Healthy
- High-intensity and short-duration
- +3 more
-
Valencia, SpainIonclinics & DEIONICS.
Jan 11, 2023
Uterocervical Angle in Prediction of Preterm Labor
Completed
- Preterm Labor
-
Cairo, EgyptAinShams university maternity hospital
Jan 28, 2023
COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein
Active, not recruiting
- COVID-19
- SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
- +10 more
-
Birmingham, Alabama
- +71 more
Jul 11, 2022